Companies /Healthcare
Adc Therapeutics SA
NYSE: ADCT Drug Manufacturers - Specialty & Generic
$1.43
▼ $0.28 (−16.18%) today
Markets open · 3:06pm ET

ADC Therapeutics (ADCT) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
80%
EPS beat rate
+49.64%
Avg. EPS surprise
Consecutive EPS beats
ADCT vs Market · 30-day return after each reportADCTS&P 500
−60%−30%0%+12.6%+2.3%Q2 25−0.7%+1.1%Q3 25−22.1%+0.3%Q4 25−64.1%+5.4%Q1 26+3.8%−2.6%Q2 26
−60%−30%0%Q2 25Q3 25Q4 25Q1 26Q2 26
ADCT EPS Trend · estimate vs actualEstimateActual
$-0.40$-0.20$0.00$-0.25Q2 25$-0.36$-0.19Q3 25$-0.27$-0.09Q4 25$-0.20$-0.13Q1 26$-0.22$-0.11Q2 26
$-0.40$-0.20Q2 25Q3 25Q4 25Q1 26Q2 26
ADCT Revenue Trend · estimate vs actualEstimateActual
$0$7.0M$14.0M$21.0M$17.9M$18.8MQ2 25$16.8M$16.4MQ3 25$22.3M$23.1MQ4 25$20.0M$20.9MQ1 26$18.9M$19.2MQ2 26
$0$7.0M$14.0M$21.0MQ2 25Q3 25Q4 25Q1 26Q2 26

How Often Does ADC Therapeutics Beat Earnings Estimates?

ADC Therapeutics beat EPS estimates in 4 of its last 5 reported quarters, and has beaten 4 quarters in a row.

ADCT quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $-0.11 est. $-0.22 +49.07% $19.2M est. $18.9M +1.86%
Q1 2026 $-0.13 est. $-0.20 +35.55% $20.9M est. $20.0M +4.32%
Q4 2025 $-0.09 est. $-0.27 +66.46% $23.1M est. $22.3M +3.43%
Q3 2025 $-0.19 est. $-0.36 +47.47% $16.4M est. $16.8M −2.18%
Q2 2025 $-0.25 est. $0.00 — $18.8M est. $17.9M +5.48%

Figures from SEC filings and company reports. Not investment advice.